Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2013 Nov 7;8(11):e79771.
doi: 10.1371/journal.pone.0079771. eCollection 2013.

Alzheimer's disease: analyzing the missing heritability

Collaborators, Affiliations
Multicenter Study

Alzheimer's disease: analyzing the missing heritability

Perry G Ridge et al. PLoS One. .

Abstract

Alzheimer's disease (AD) is a complex disorder influenced by environmental and genetic factors. Recent work has identified 11 AD markers in 10 loci. We used Genome-wide Complex Trait Analysis to analyze >2 million SNPs for 10,922 individuals from the Alzheimer's Disease Genetics Consortium to assess the phenotypic variance explained first by known late-onset AD loci, and then by all SNPs in the Alzheimer's Disease Genetics Consortium dataset. In all, 33% of total phenotypic variance is explained by all common SNPs. APOE alone explained 6% and other known markers 2%, meaning more than 25% of phenotypic variance remains unexplained by known markers, but is tagged by common SNPs included on genotyping arrays or imputed with HapMap genotypes. Novel AD markers that explain large amounts of phenotypic variance are likely to be rare and unidentifiable using genome-wide association studies. Based on our findings and the current direction of human genetics research, we suggest specific study designs for future studies to identify the remaining heritability of Alzheimer's disease.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Unexplained Alzheimer’s disease variance, by chromosome.
In this figure we show phenotypic variance, by chromosome, explained by all SNPs. Error bars correspond to standard error.
Figure 2
Figure 2. Unexplained Alzheimer’s disease variance, by chromosome, excluding known Alzheimer’s disease markers.
This figure is the same as Figure 1 except we have removed variance explained by known Alzheimer’s disease markers. Error bars correspond to standard error.
Figure 3
Figure 3. Variant search space.
Real and hypothetical variants are graphed by effect size (y-axis) and population frequency (x-axis). Known Alzheimer’s disease SNPs are blue circles and hypothetical SNPs are red circles. The large box on the right outlined with dots, is the GWAS search space and the smaller box on the left, outlined with dashes, is the next-generation sequencing search space. Known Alzheimer’s disease SNPs are those found in Table 1 as well as APP and TREM2, which are both labeled on the graph.

Similar articles

Cited by

References

    1. Querfurth HW, LaFerla FM (2010) Alzheimer's disease. N Engl J Med 362: 329-344. doi:10.1056/NEJMra0909142. PubMed: 20107219. - DOI - PubMed
    1. Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM (2007) Forecasting the global burden of Alzheimer's disease. Alzheimers Dement 3: 186-191. doi:10.1016/j.jalz.2007.04.381. PubMed: 19595937. - DOI - PubMed
    1. Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D et al. (2011) Alzheimer's disease. Lancet. - PubMed
    1. Herrup K (2010) Reimagining Alzheimer's disease--an age-based hypothesis. J Neurosci 30: 16755-16762. doi:10.1523/JNEUROSCI.4521-10.2010. PubMed: 21159946. - DOI - PMC - PubMed
    1. Patterson C, Feightner JW, Garcia A, Hsiung GY, MacKnight C et al. (2008) Diagnosis and treatment of dementia: 1. Risk assessment and primary prevention of Alzheimer disease. CMAJ 178: 548-556. doi:10.1503/cmaj.070796. PubMed: 18299540. - DOI - PMC - PubMed

Publication types

Grants and funding